Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

HemoCleanse licenses bioartificial liver technology from Monsanto

Jan. 14, 1997

OXIS files IND for BXT-51072

Jan. 13, 1997

VIMRxyn enters clinical testing in HCV-infected patients

Jan. 9, 1997

ISIS-2302 update

Jan. 9, 1997

Oxis International completes phase I testing of IBD treatment

Jan. 8, 1997

Anti-HCV agents revealed by Japanese and Chinese investigators

Jan. 8, 1997

Prokinetic agents from Tokyo Tanabe

Jan. 8, 1997

Shin Nippon discloses antiulcer agents

Jan. 7, 1997

Lansoprazole equieffective to omeprazole in Dutch trial

Jan. 2, 1997

Novel human serine protease inhibitor for pancreatitis claimed by Incyte

Jan. 2, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
Chengdu Mfs Pharma synthesizes new compounds for pain
BioWorld Science
Chengdu Mfs Pharma Co. Ltd. has prepared and tested compounds for the potential treatment of pain, sleep disorder and status epilepticus epilepsy as well as for...